Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. DFTX
3. SPCX
4. FRVO
5. MPLT
6. CART
7. HIVE
8. INTC
9. APGE
10. ABBV

Go back to Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
(AMEX: MKKGY) Delayed: 30.75 --0 (-0%)
Previous Close $30.75    52 Week High $ 
Open $30.75    52 Week Low $ 
Day High $30.75    P/E N/A 
Day Low $30.75    EPS $ 
Volume 23       

Merck & Co. (NYSE: MRK) Delayed: 113.87 --0 (-0%)
Previous Close $113.87    52 Week High $65.46 
Open $113.87    52 Week Low $47.97 
Day High $113.87    P/E 77.46 
Day Low $113.87    EPS $1.47 
Volume 9,082       

Merck & Co. (NYSE: MRK) Delayed: 113.87 --0 (-0%)
Previous Close $113.87    52 Week High $65.46 
Open $113.87    52 Week Low $47.97 
Day High $113.87    P/E 77.46 
Day Low $113.87    EPS $1.47 
Volume 9,082       

BANK OF AMERICA, STARS LINKED TO THE S&P 500 DUE 4/5/2011 (NYSE: SEO) Delayed: 11.83 --0 (-0%)
Previous Close $11.83    52 Week High $29.87 
Open $1152.15    52 Week Low $9.86 
Day High $11.83    P/E N/A 
Day Low $11.83    EPS $0.00 
Volume 23,583